These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8852537)

  • 1. The cardiac and vascular effects of lacidipine.
    Agabiti-Rosei E
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S1-5. PubMed ID: 8852537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radial artery compliance in essential hypertension: effects of antihypertensive therapy with lacidipine.
    Trazzi S; Santucciu C; Mancia G
    J Hypertens Suppl; 1993 Dec; 11(6):S17-20. PubMed ID: 8169377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of calcium antagonists on the cardiovascular system: experience with lacidipine.
    Kuschnir E
    Drugs; 1999; 57 Suppl 1():11-7. PubMed ID: 10529078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of the effects of lacidipine and enalapril on the left ventricular cardiomyocyte remodeling in spontaneously hypertensive rats.
    Cagalinec M; Kyselovic J; Blaskova E; Bacharova L; Chorvat D; Chorvatova A
    J Cardiovasc Pharmacol; 2006 Apr; 47(4):561-70. PubMed ID: 16680070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lacidipine on the carotid and cerebral circulations in essential hypertension.
    Safar ME
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S51-4. PubMed ID: 1726008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of lacidipine: a review of animal and human data.
    Mancia G; Ferrari AU; Giannattasio C; Trazzi S
    J Hypertens Suppl; 1993 Mar; 11(1):S39-43. PubMed ID: 8483021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of lacidipine, a vascular-selective calcium antagonist.
    Micheli D; Ratti E; Toson G; Gaviraghi G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effects on blood pressure and left ventricular hypertrophy of lacidipine and hydrochlorothiazide in hypertensive patients.
    Leonetti G; Fogari R; Mazzola C; Mangiameli S; Castello C
    J Hypertens Suppl; 1991 Dec; 9(3):S29-31. PubMed ID: 1839161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Malmberg L; Teräväinen TL; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preclinical study of the action of a calcium channel blocker during salt load].
    Godfraind T; Salomone S; Morel N; Ghisdal P
    Bull Acad Natl Med; 1997 Feb; 181(2):289-98; discussion 299-300. PubMed ID: 9235228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective action of lacidipine in cardiac hypertrophy of the spontaneously hypertensive stroke-prone rat: an ultrastructural study.
    Cristofori P; Sbarbati A; Accordini C; Terron A; Micheli D
    J Submicrosc Cytol Pathol; 1994 Jul; 26(3):331-40. PubMed ID: 8087797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacology of lacidipine.
    Hall ST; Harding SM; Evans GL; Pellegatti M; Rizzini P
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S9-13. PubMed ID: 1726014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    Zaliūnas R; Brazdzionyte J; Zabiela V; Jurkevicius R
    Int J Cardiol; 2005 Jun; 101(3):347-53. PubMed ID: 15907400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential role of calcium antagonists in the management of congestive heart failure: initial experience with lacidipine.
    de Vries RJ; Dunselman PH
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S33-9. PubMed ID: 8852543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural changes of small resistance arteries in spontaneously hypertensive rats after treatment with various doses of lacidipine.
    Porteri E; Rizzoni D; Castellano M; Bettoni G; Muiesan ML; Salvetti M; Quartaroli M; Gaviraghi G; Rosei EA
    J Hypertens; 1997 Jun; 15(6):619-25. PubMed ID: 9218181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonism: aldosterone and vascular responses to catecholamines and angiotensin II in man.
    Elliott HL
    J Hypertens Suppl; 1993 Dec; 11(6):S13-6. PubMed ID: 8169376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Na+/K+-ATPase alpha isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment.
    Quintas LE; Noël F; Wibo M
    Eur J Pharmacol; 2007 Jun; 565(1-3):151-7. PubMed ID: 17451677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.